Choundhry et al. reported that high HIF-2α levels are a contributing factor to the activation of NEAT1 [70], which functions as an oncogene in NSCLC, according to Kong et al. [71]. The gene discussed is EPAS1; the disease is non-small cell lung carcinoma.